olivLaw · US equity research
Braskem S.A. BAK
Industrial Organic Chemicals · SIC 2860 · Vertical: Industrial Organic Chemicals (SIC 2860)
Braskem is the largest plastics producer in the Americas, with integrated operations in Brazil and Mexico and a global leadership position in sugarcane-based bio-polyethylene. The company faces a change in its shareholder structure through a judicial sale of a major block of shares, amid pressure on the petrochemical cycle.
The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).
At the close of 04 Nov 2026, Braskem S.A. (BAK) stock was 1.12 USD (+0.90% on the day), with beta 1.23, 52-week range 1.10–5.02 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 34.1
- weak (30–45)
- Bollinger (20, 2)
- 0.93 – 2.10
- in the lower half of the band · %B 0.16 · band width 77.2%
- SMA 50 / 200
- 1.64 / 3.01
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.17 / -0.12
- MACD below signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −30.4% | −1.1% | −29.3 pp | — |
| 3 months | −50.4% | −0.5% | −50.0 pp | — |
| 6 months | −71.0% | +4.4% | −75.4 pp | — |
| Year to date | −62.0% | +12.3% | −74.4 pp | — |
| 1 year | −53.5% | +13.5% | −67.1 pp | −1.7% |
| 3 years | −84.5% | +76.4% | −160.9 pp | −26.4% |
| 5 years | −94.4% | +63.7% | −158.0 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
the price (USD) and the reports are in different currencies
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2017 | 2018 | 2019 | 2020 | ⚠ 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 49.3 bn | 58.0 bn | 52.3 bn | 58.5 bn | 105.6 bn | 96.5 bn | 70.6 bn | 77.4 bn |
| Revenue YoY | +3.3% | +17.7% | −9.8% | +11.9% | — | −8.6% | −26.9% | +9.7% |
| Net income | 3.9 bn | 2.8 bn | -2.5 bn | -6.7 bn | 14.0 bn | -336.0 m | -4.6 bn | -11.3 bn |
| Net income YoY | unavailable | −26.8% | −189.9% | unavailable | — | −102.4% | unavailable | unavailable |
| Diluted EPS | unavailable | unavailable | -3.19 | -8.41 | 17.57 | unavailable | unavailable | unavailable |
| Diluted EPS YoY | unavailable | unavailable | unavailable | unavailable | — | unavailable | unavailable | unavailable |
| net % | 7.8% | 4.9% | -4.9% | -11.4% | 13.2% | -0.3% | -6.5% | -14.6% |
| Free cash flow | 188.4 m | 6.5 bn | -417.2 m | 3.5 bn | 11.4 bn | 4.1 bn | -6.8 bn | -1.3 bn |
The series breaks before 2021: earlier years come from the original reports of the issuer of that time, later years from a subsequent filing that restated the perimeter (a separation, discontinued operations). The year-on-year change across the break is not shown.
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2024 · 31 Dec 2024
- Cash
- 15.0 bn BRL
- Financial debt
- 53.2 bn BRL
- Net debt
- 38.2 bn BRL
- Equity
- -4.3 bn BRL
- Total assets
- 101.6 bn BRL
- Debt / equity
- unavailable
- Current ratio
- 1.31x
- ROE
- unavailable
- ROA
- -11.7%
- FCF margin
- -1.7%
Financial statements (source on every figure)
Revenue and net income (BRL)
Margins
Income statement · BRL
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 52.3 bn | 58.5 bn | 105.6 bn | 96.5 bn | 70.6 bn | 77.4 bn | SEC (XBRL)· 31 Mar 2025verified |
| Cost of revenue | 45.9 bn | 47.3 bn | 73.6 bn | 85.2 bn | 67.5 bn | 71.4 bn | SEC (XBRL)· 31 Mar 2025verified |
| Gross profit | 6.4 bn | 11.2 bn | 32.1 bn | 11.4 bn | 3.0 bn | 6.0 bn | SEC (XBRL)· 31 Mar 2025verified |
| Research & development | 247.7 m | 250.6 m | 297.0 m | 374.0 m | 383.0 m | 463.0 m | SEC (XBRL)· 31 Mar 2025verified |
| Operating income | 153.7 m | -71.9 m | 26.0 bn | 4.3 bn | -2.8 bn | -1.1 bn | SEC (XBRL)· 31 Mar 2025verified |
| Interest expense | 3.9 bn | 4.9 bn | 4.9 bn | 5.1 bn | 5.6 bn | 6.9 bn | SEC (XBRL)· 31 Mar 2025verified |
| Pre-tax income | -4.6 bn | -9.7 bn | 18.0 bn | 47.0 m | -6.2 bn | -17.7 bn | SEC (XBRL)· 31 Mar 2025verified |
| Income tax | -2.0 bn | -2.7 bn | 4.0 bn | 868.0 m | -1.3 bn | -5.7 bn | SEC (XBRL)· 31 Mar 2025verified |
| Net income | -2.5 bn | -6.7 bn | 14.0 bn | -336.0 m | -4.6 bn | -11.3 bn | SEC (XBRL)· 31 Mar 2025verified |
| Diluted EPS | -3.19 | -8.41 | 17.57 | — | — | — | SEC (XBRL)· 28 Apr 2022verified |
| Dividend per share | 1.48 | 0.01 | 13.27 | 2.99 | 0.02 | 0.01 | SEC (XBRL)· 31 Mar 2025derived |
Balance sheet · BRL
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 6.8 bn | 13.9 bn | 8.7 bn | 12.5 bn | 14.2 bn | 15.0 bn | SEC (XBRL)· 31 Mar 2025verified |
| Inventories | 7.6 bn | 8.4 bn | 16.3 bn | 14.0 bn | 12.5 bn | 13.7 bn | SEC (XBRL)· 31 Mar 2025verified |
| Current assets | 23.4 bn | 34.2 bn | 39.3 bn | 34.5 bn | 37.4 bn | 37.0 bn | SEC (XBRL)· 31 Mar 2025verified |
| Property, plant & equipment, net | 32.3 bn | 35.9 bn | 37.2 bn | 37.8 bn | 38.4 bn | 40.4 bn | SEC (XBRL)· 31 Mar 2025verified |
| Intangibles (excl. goodwill) | 2.8 bn | 2.8 bn | 2.9 bn | — | — | — | SEC (XBRL)· 28 Apr 2022verified |
| Total assets | 68.1 bn | 86.1 bn | 92.6 bn | 88.0 bn | 91.7 bn | 101.6 bn | SEC (XBRL)· 31 Mar 2025verified |
| Accounts payable | 9.1 bn | 9.9 bn | 12.1 bn | 12.2 bn | 13.2 bn | 16.9 bn | SEC (XBRL)· 31 Mar 2025verified |
| Short-term debt | 774.9 m | 1.3 bn | 1.3 bn | 1.4 bn | 2.0 bn | 2.3 bn | SEC (XBRL)· 31 Mar 2025verified |
| Long-term debt | 28.2 bn | 40.4 bn | 33.6 bn | 34.3 bn | 40.2 bn | 51.0 bn | SEC (XBRL)· 31 Mar 2025verified |
| Current liabilities | 16.2 bn | 28.4 bn | 25.2 bn | 24.2 bn | 24.5 bn | 28.3 bn | SEC (XBRL)· 31 Mar 2025verified |
| Total liabilities | — | — | 4.2 bn | 3.0 bn | — | — | SEC (XBRL)· 25 Apr 2023verified |
| Equity | 3.9 bn | -3.9 bn | 6.2 bn | 6.1 bn | 3.3 bn | -4.3 bn | SEC (XBRL)· 31 Mar 2025verified |
| Shares outstanding at year end | 451.7 m | 451.7 m | 451.7 m | 451.7 m | 451.7 m | 451.7 m | SEC (XBRL)· 31 Mar 2025verified |
Cash flow · BRL
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.3 bn | 6.3 bn | 14.8 bn | 9.0 bn | -2.3 bn | 2.4 bn | SEC (XBRL)· 31 Mar 2025verified |
| Capex | 2.7 bn | 2.8 bn | 3.4 bn | 4.8 bn | 4.5 bn | 3.8 bn | SEC (XBRL)· 31 Mar 2025verified |
| Free cash flow | -417.2 m ≈ | 3.5 bn ≈ | 11.4 bn ≈ | 4.1 bn ≈ | -6.8 bn ≈ | -1.3 bn ≈ | SEC (XBRL)· 31 Mar 2025derived |
| Investing cash flow | -2.7 bn | -2.7 bn | -3.4 bn | -4.9 bn | -4.5 bn | -3.5 bn | SEC (XBRL)· 31 Mar 2025verified |
| Financing cash flow | 1.6 bn | 2.2 bn | -17.0 bn | 225.0 m | 8.9 bn | 469.0 m | SEC (XBRL)· 31 Mar 2025verified |
| Dividends paid | 668.9 m | 2.4 m | 6.0 bn | 1.4 bn | 7.0 m | 6.0 m | SEC (XBRL)· 31 Mar 2025verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
Risk
Valuation
olivLaw classification
- indicators available: 4 of at least 6
- score weight coverage: 25.0% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: unavailable
Price and reporting are in different currencies; market indicators are unavailable.
Key indicators
Coverage and freshness
The data is older than the freshness threshold.
Score by group
25% · Insufficient data
Estimated value range
unavailable — no valuation assumptions for the reporting currency
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 6.5%
- Equity risk premium
- 6.0%
- Beta (default)
- 1.00
- Cost of equity
- 12.5%
- Terminal growth
- 3.0%
Factor scorecard
Insufficient data
Minimum-evidence gate: indicators available: 4 of at least 6; score weight coverage: 25.0% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | -14.6% | 42 (vs peers) | 25% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | -9.8% | 0 (on a fixed band) | 33% |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | -0.2x | 0 (on a fixed band) | 25% |
| Current ratio · Balance sheet | 1.3x | 43 (on a fixed band) | 17% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | unavailable | unavailable | — |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet17/100 · 2/3 factors with a value
- Growth· partial0/100 · 1/2 factors with a value
- Quality· partial42/100 · 1/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation· partialunavailable · 0/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
BRASKEM SA (BAK). Latest full fiscal year: 2024; data up to 2024-12-31.
Figures computed from the financial statements: revenue 77.4 bn BRL in 2024; YoY growth 9.7%; net margin -14.6%.
The estimated value range is 0.13–0.16 BRL per share (median of 1 methods, agreement: single method); assumptions are illustrative. The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (indicators available: 4 of at least 6; score weight coverage: 25.0% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.
What contradicts it
- Revenue CAGR 3Y: -9.8%
- Interest coverage: -0.2x
Not assessed (insufficient data or a ratio without meaning): ROIC, FCF conversion, EPS CAGR 3Y, Net debt / EBITDA, P/E (TTM), EV/EBITDA, FCF yield, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Industrial Organic Chemicals (SIC 2860) · same industry (4-digit SIC) · compared with 20 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| IFFInternational Flavors & Fragrances Inc | 22.0 bn | 122.1 | 1.3% | 1.6% | −5.2% | +26% / +16% |
| LYBLyondellbasell Industries N.V. | 20.4 bn | 15.6 | 11.9% | 4.1% | −9.7% | +29% / −34% |
| WLKWestlake Corporation | 8.7 bn | — | -4.9% | -3.9% | −8.0% | +2% / −47% |
| NEUNewmarket Corporation | 6.7 bn | 14.7 | 25.3% | 16.5% | −2.2% | −5% / +37% |
| SXTSensient Technologies Corp | 5.4 bn | 31.7 | 13.7% | 9.7% | +3.5% | +29% / +117% |
| MEOHMethanex Corporation | 5.0 bn | 70.1 | 6.4% | 4.0% | −3.5% | +83% / +53% |
| REXRex American Resources Corporation | 1.3 bn | 10.5 | 22.5% | 20.9% | +1.2% | +20% / +62% |
| GPREGreen Plains Inc. | 957.5 m | 8.6 | 15.4% | 6.8% | −14.9% | +32% / −45% |
| WLKPWestlake Chemical Partners LP | 761.8 m | 12.9 | — | 4.8% | +2.7% | +14% / −5% |
| GEVOGevo, Inc. | 316.5 m | — | -57.0% | -119.9% | +849.3% | −40% / +13% |
| ALTOAlto Ingredients, Inc. | 271.5 m | 5.3 | 22.2% | 5.5% | −4.9% | +37% / +43% |
| FFFuturefuel Corp. | 246.5 m | — | -18.3% | -19.9% | −60.7% | +70% / −5% |
| CDXSCodexis, Inc. | 118.3 m | — | -69.4% | -39.6% | +18.6% | −38% / −54% |
| LODEComstock Inc. | 113.3 m | — | -38.2% | -3,680.5% | −48.5% | −58% / −68% |
| AMTXAemetis, Inc | 90.2 m | — | — | -27.4% | −26.2% | −28% / −72% |
| TANHTantech Holdings Ltd | 90.1 m | — | -25.7% | -80.9% | −10.7% | −76% / −100% |
| LNZALanzaTech Global, Inc. | 69.2 m | 0.4 | 146.4% | 295.7% | +12.6% | −63% / −99% |
| SAFXXcf Global, Inc. | 41.0 m | — | -246.1% | — | unavailable | −87% / unavailable |
| TOMZTomi Environmental Solutions, Inc. | 18.2 m | — | -168.8% | -49.8% | −27.2% | −6% / −26% |
| CNEYCn Energy Group. Inc. | 2.5 m | — | -11.2% | -31.3% | −30.2% | −65% / −99% |
| BAKBraskem SA | — | — | — | -14.6% | +9.7% | −54% / −84% |
1- and 3-year price returns: for BAK from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Scenarios are not available. input data missing
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 20 Apr 2026; since then the company filed 6-K (04 Nov 2026), 6-K (02 Nov 2026), 6-K (30 Oct 2026), 6-K (28 Oct 2026), 6-K (26 Oct 2026).
In brief
Braskem is the largest plastics producer in the Americas, with integrated operations in Brazil and Mexico and a global leadership position in sugarcane-based bio-polyethylene. The company faces a change in its shareholder structure through a judicial sale of a major block of shares, amid pressure on the petrochemical cycle.1
SWOT
Strengths
- The company is the largest plastics producer in the Americas and the only integrated producer of basic chemicals and polymers in Brazil.
- Global leadership in sugarcane-based bio-polyethylene gives it a differentiation advantage over fossil alternatives.
- Utilization rates at its U.S. and Mexican plants have consistently exceeded regional averages, indicating sound operations.
Weaknesses
- The company relies heavily on naphtha, whose price was volatile in 2025, which can affect production costs.
- Currency exposure is significant, since much of its debt and raw material costs are linked to the U.S. dollar while revenue is largely in reais.
- The level of indebtedness and capital needs for large projects may limit financial flexibility.
Opportunities
- Demand for plastics could grow over the long term with economic growth and infrastructure investment.
- Green ethylene projects and the bioMEG and bioMPG joint ventures could open new revenue lines.
- Brazilian programs supporting the chemical industry, such as PRESIQ and REIQ, could reduce costs and support investment.
Threats
- Global oversupply, especially from China, could keep prices and margins under pressure over the medium term.
- Judicial and tax proceedings, including a public civil action and new tax assessments, could have financial impact if losses become probable.
- The judicial sale of a major share block introduces uncertainty over governance and shared control with Petrobras.
Risks
- Judicial sale of shareshigh
The judicial sale to an investment fund of a major block of the company's shares is subject to conditions precedent, including judicial and antitrust approvals. If the transaction does not close, the control structure could remain uncertain.
- Public civil action in Alagoashigh
The lawsuit filed by the Public Defender's Office and an association of affected entrepreneurs could lead to significant compensation, although the company classifies the likelihood of loss as possible.
- New tax assessmentsmedium
Notices received in the first quarter of 2026 concerning federal taxes offset against PIS and COFINS credits could generate additional costs if authorities prevail.
- Raw material price volatilitymedium
Naphtha and propylene prices fluctuated significantly in 2025, and these swings could affect margins if they cannot be fully passed on to customers.
- Exchange rate exposuremedium
Appreciation or depreciation of the real against the dollar affects revenue, costs and debt, and the company acknowledges these effects can be significant.
Investment thesis
What would need to be true (bull case)
- If polymer demand grows in line with medium-term expectations, the position as the largest producer in the Americas could support volumes and margins.
- Brazilian trade protection and fiscal support programs could reduce import competition pressure and improve competitiveness.
- Leadership in bio-based polyethylene and green ethylene projects could generate niche revenue with better margins than standard products.
What would break the thesis
- If Chinese oversupply persists, polymer prices could stay under pressure and limit margin recovery.
- Judicial actions, tax assessments and uncertainty over control could generate costs and slow strategic decisions.
- Currency exposure and debt levels could amplify the impact of exchange rate and interest rate shocks on results.
What to watch
- Completion of the judicial share sale and its conditions precedent2026
- Final investment decision for the green ethylene plant in Thailandend of 2026
- Naphtha price trend and Brazil segment resultsQ1 2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 20 Apr 2026; since then the company filed 6-K (04 Nov 2026), 6-K (02 Nov 2026), 6-K (30 Oct 2026), 6-K (28 Oct 2026), 6-K (26 Oct 2026).
The business
The main revenue contributors are the Brazil segment, which generated most of consolidated net revenue in fiscal 2025, followed by the United States and Europe segment producing polypropylene and the Mexico segment producing ethylene and polyethylene. The company describes its global installed capacity as 20,325 kton per year. Currency exposure is significant, since product prices are substantially linked to international prices quoted in U.S. dollars.1
The global strategy focuses on financial resilience, optimization of the asset portfolio and transformative investments in bio-based projects, such as the green ethylene expansion at Triunfo and the joint ventures for bioMEG, bioMPG and a plant in Thailand. The company also points to Brazilian programs defending the chemical industry, including antidumping duties on imported resins.1
Segments
Brazil
The Brazil segment covers production and sale of chemicals and polymers at the Camaçari, Triunfo, Capuava and Duque de Caxias complexes, plus electricity and other inputs supplied to second-generation producers. It generated net revenue of R$51,774 million in fiscal 2025, or 72% of consolidated net revenue.1
United States and Europe
The United States and Europe segment produces and sells polypropylene in the United States and Germany. It generated net revenue of R$16,400 million in fiscal 2025, or 23% of the consolidated total, and its Delta project, a greenfield PP plant in La Porte, Texas, started in 2020.1
Mexico
The Mexico segment includes production of ethylene, HDPE and LDPE through the Braskem Idesa joint venture. It generated net revenue of R$4,103 million in fiscal 2025, or 6% of the total, and the company stresses access to competitively priced gas-based feedstock.1
Trends
- Substitution of traditional materialstailwind
The company states that polymers increasingly replace materials such as aluminum, steel, wood and glass where they offer cost and performance advantages, which could support long-term demand.
- Global petrochemical oversupplyheadwind
Capacity additions in China and the competitiveness of natural gas and ethane in the United States and the Middle East have created oversupply and reduced naphtha's share, which could pressure prices and margins.
- Trade protection in Braziltailwind
Inclusion of PE, PP and PVC resins on the list of conjunctural trade imbalances and antidumping duties on imports from China, Canada and the United States could support domestic production.
- Shift to bio-based feedstockmixed
Demand for renewable-sourced products and green ethylene projects could open new revenue streams, but investment costs and execution risk remain high.
Competitive position
The company compares itself with other petrochemical producers in the Americas and globally, emphasizing that it is the only integrated producer of basic chemicals and polymers in Brazil. Import competition, mainly from the Middle East and Asia, is limited by freight costs and import tariffs, but global overcapacity remains a pressure.1
In bio-based polyethylene, Braskem states it holds global leadership, and in polypropylene a leading position in the United States. The source does not name direct competitors, so quantitative comparisons remain limited.1
- Middle East polymer producers
Exporters of polymers into Brazil that face import tariffs, according to the company.
- Chinese chemical producers
Newly added capacity has created industry oversupply, and their resin imports are subject to Brazilian antidumping duties.
- U.S. polyethylene and polypropylene producers
Access to competitively priced natural gas and ethane has let them reduce dependence on naphtha.
- Southeast Asian polyethylene producers
Regional competitors in export markets that benefit from new petrochemical capacity.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
- Braskem Creditor Bracebridge Starts Involuntary Chapter 11 CaseBloomberg Markets · 21 Oct 2026 · EN
- Braskem Creditors Balk at Restructuring Plan as Deadline LoomsBloomberg Markets · 07 Oct 2026 · EN
- Petrobras Executive Says Braskem to Reach Deal With CreditorsBloomberg Markets · 24 Sept 2026 · EN
- Braskem Creditors Shun Debt Plan, Push Owners to Inject CashBloomberg Markets · 17 Sept 2026 · EN
- Offshore Bondholders Emerge as Main Backers of Braskem’s ReworkBloomberg Markets · 26 Aug 2026 · EN
- Braskem’s $11 Billion Debt Rework Puts Spotlight on PetrobrasBloomberg Markets · 25 Aug 2026 · EN
- Brazil’s Braskem Files for Out-of-Court Debt Rework, Estado SaysBloomberg Markets · 24 Aug 2026 · EN
- Braskem Debt Talks Drag on With No Deal Days Ahead of DeadlineBloomberg Markets · 21 Aug 2026 · EN
- Braskem’s Mexico Unit Files for Chapter 11 Bankruptcy in USBloomberg Markets · 18 Aug 2026 · EN
- Petrobras Mulls Improving Braskem Credit Terms Amid Debt TalksBloomberg Markets · 17 Aug 2026 · EN
- Braskem Optimistic on Talks With Creditors as Deadline LoomsBloomberg Markets · 14 Aug 2026 · EN
- Petrochemicals Maker Braskem Beats Estimates Amid Cash WoesBloomberg Markets · 14 Aug 2026 · EN
- Braskem Creditors Seek Petrobras Capital as Deal Deadline LoomsBloomberg Markets · 10 Aug 2026 · EN
- Braskem Seeks Emergency Protection as Debt Talks Hit SnagsBloomberg Markets · 25 Jun 2026 · EN
- Elliott, SVP Buy Braskem Debt Amid Restructuring TalksBloomberg Markets · 18 Jun 2026 · EN
- Braskem Debt Talks Hit Snag, Boosting Odds of Emergency OrderBloomberg Markets · 18 Jun 2026 · EN
- Petrochemicals Giant Braskem Seeks Support to Start Out-of-Court ReworkBloomberg Markets · 02 Jun 2026 · EN
- Cash Crunch Leaves Braskem’s Mexico Unit Missing Out on Oil BoomBloomberg Markets · 20 May 2026 · EN
The latest news item in our archive is from 21 Oct 2026; the newest SEC filing is from 04 Nov 2026. The press archive comes from the RSS feeds we follow and does not necessarily cover the latest event — the filings alongside do.
SEC filings
- Current report (foreign issuer)04 Nov 2026
- Current report (foreign issuer)02 Nov 2026
- Current report (foreign issuer)02 Nov 2026
- Current report (foreign issuer)30 Oct 2026
- Current report (foreign issuer)28 Oct 2026
- Current report (foreign issuer)26 Oct 2026
- Current report (foreign issuer)22 Oct 2026
- Current report (foreign issuer)22 Oct 2026
- Current report (foreign issuer)22 Oct 2026
- Current report (foreign issuer)13 Oct 2026
Sources
- [1] Form 20-F, fiscal year ended 2025-12-31 · SEC / Braskem S.A. · 20 Apr 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.